Originally published In Press as doi:10.1074/jbc.M401803200 on August 5, 2004
J. Biol. Chem., Vol. 279, Issue 42, 43780-43788, October 15, 2004
A Neutralizing Anti-Nogo66 Receptor Monoclonal Antibody Reverses Inhibition of Neurite Outgrowth by Central Nervous System Myelin*
Weiwei Li
,
Lee Walus
,
Sylvia A. Rabacchi
,
Adrienna Jirik
,
Ernie Chang
,
Jessica Schauer
,
Betty H. Zheng
,
Nancy J. Benedetti
,
Betty P. Liu
,
Eugene Choi
,
Dane Worley
,
Laura Silvian
,
Wenjun Mo
,
Colleen Mullen
,
Weixing Yang
,
Stephen M. Strittmatter
,
Dinah W. Y. Sah
,
Blake Pepinsky
, and
Daniel H. S. Lee
¶
From the
Biogen Idec, Inc., Cambridge, Massachusetts 02142 and the
Department of Neurology, Yale University School of Medicine, New Haven, Connecticut 06150
The Nogo66 receptor (NgR1) is a neuronal, leucinerich repeat (LRR) protein that binds three central nervous system (CNS) myelin proteins, Nogo, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein, and mediates their inhibitory effects on neurite growth. Although the LRR domains on NgR1 are necessary for binding to the myelin proteins, the exact epitope(s) involved in ligand binding is unclear. Here we report the generation and detailed characterization of an anti-NgR1 monoclonal antibody, 7E11. The 7E11 monoclonal antibody blocks Nogo, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein binding to NgR1 with IC50 values of 120, 14, and 4.5 nM, respectively, and effectively promotes neurite outgrowth of P3 rat dorsal root ganglia neurons cultured on a CNS myelin substrate. Further, we have defined the molecular epitope of 7E11 to be DNAQLR located in the third LRR domain of rat NgR1. Our data demonstrate that anti-NgR1 antibodies recognizing this epitope, such as 7E11, can neutralize CNS myelin-dependent inhibition of neurite outgrowth. Thus, specific anti-NgR1 antibodies may represent a useful therapeutic approach for promoting CNS repair after injury.
Received for publication, February 18, 2004
, and in revised form, July 13, 2004.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Biogen Idec Inc., 14 Cambridge Center, Cambridge, MA 02142. Tel.: 617-679-2563; Fax: 617-679-3200; E-mail: Daniel_Lee{at}biogenidec.com.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. K. Seabold, P. Y. Wang, K. Chang, C.-Y. Wang, Y.-X. Wang, R. S. Petralia, and R. J. Wenthold
The SALM Family of Adhesion-like Molecules Forms Heteromeric and Homomeric Complexes
J. Biol. Chem.,
March 28, 2008;
283(13):
8395 - 8405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Mehta, P. H. H. Lopez, A. A. Vyas, and R. L. Schnaar
Gangliosides and Nogo Receptors Independently Mediate Myelin-associated Glycoprotein Inhibition of Neurite Outgrowth in Different Nerve Cells
J. Biol. Chem.,
September 21, 2007;
282(38):
27875 - 27886.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. B. J. Cafferty, S.-H. Yang, P. J. Duffy, S. Li, and S. M. Strittmatter
Functional Axonal Regeneration through Astrocytic Scar Genetically Modified to Digest Chondroitin Sulfate Proteoglycans
J. Neurosci.,
February 28, 2007;
27(9):
2176 - 2185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Venkatesh, O. Chivatakarn, H. Lee, P. S. Joshi, D. B. Kantor, B. A. Newman, R. Mage, C. Rader, and R. J. Giger
The Nogo-66 Receptor Homolog NgR2 Is a Sialic Acid-Dependent Receptor Selective for Myelin-Associated Glycoprotein
J. Neurosci.,
January 26, 2005;
25(4):
808 - 822.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.